JPRN-UMIN000019865
Completed
未知
A Phase II clinical trial to evaluate the efficacy and safety of intra-arterial infusion chemotherapy for head and neck squamous cell carcinoma - A Phase II clinical trial of intra-arterial infusion chemotherapy for head and neck SCC
Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University0 sites40 target enrollmentNovember 20, 2015
Conditionshead and neck squamous cell carcinoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- head and neck squamous cell carcinoma
- Sponsor
- Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. History of intolerance or hypersensitivity to drugs which will be used or any excipient of the product. 2\. Current pregnancy 3\. Current known active infection 4\. Uncontrolled diabetes 5\. Severe heart disease 6\. Severe pulmonary disease 7\. Patients who are judged to be inappropriate for participation in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
A phase II clinical Trial for evaluating efficacy and safety of PDR001(Spartalizumab) in concurrent plus consolidation versus consolidation only in addition to standard chemotherapy in unresectable stage III NSCLC patients(PASTURE)KCT0004933Yonsei University Health System, Severance Hospital200
Active, not recruiting
Phase 2
A Clinical Study to evaluate the efficacy and safety of NRC-AN-019 in cancer patients failing prior standard therapiesHealth Condition 1: null- 1. Patients with metastatic or locally advanced or inoperable solid tumors who have received prior treatment2. Chronic Myeloid Leukemia patients who are resistant and/or intolerant to ImatinibCTRI/2013/06/003768ATCO Pharma Limited
Recruiting
Phase 2
Phase II Clinical Study to evaluate the efficacy and safety of NRC-2694-AHealth Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynxCTRI/2019/06/019649ATCO Pharma Ltd
Active, not recruiting
Phase 1
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2017-000810-44-ESFundació Sant Joan de Déu30
Active, not recruiting
Not Applicable
Clinical Trial testing the combination of MK-5172 and MK-8742 with Ribavirin in people with Hepatitis CHepatitis C Virus Genotype 2, 4, 5 and 6MedDRA version: 16.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 16.1Level: LLTClassification code 10047457Term: Viral hepatitis CSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2013-002169-21-GBMerck Sharp & Dohme Corp.100